Here's why these stocks are up in premarket trading today.
Klotho Neurosciences Inc.'s (KLTO) novel secreted-Klotho (s-KL) promoter, gene, and delivery system (KLTO-202, or s-KL-AAV.myo) has been granted Orphan Drug Designation by the FDA for the treatment of Amyotrophic Lateral Sclerosis. The company is pioneering the development of novel, disease-modifying cell and gene therapies using a patented, secreted form of the anti-aging Klotho gene (s-KL) to transform the treatment of neurodegenerative and age-related disorders such as ALS, Alzheimer's, and Parkinson's disease. Shares are up 24% at $1.70.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com